Clinical Trial Update: Using Ferumoxytol-Enhanced MRI to Measure Inflammation in Patients With Brain Tumors or Other Conditions of the CNS [EARLY_Phase 1]

View source ↗

Summary

An early-phase clinical trial update evaluating ferumoxytol-enhanced MRI to measure inflammation in patients with brain tumors and other CNS conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Injury
• Brain Neoplasms
• Central Nervous System Degenerative Disorders
• Central Nervous System Infection
• Cerebral Vascular Malformations
• Intracerebral Hemorrhage
• Stroke

Drugs mentioned

• Ferumoxytol (Feraheme) (ferumoxytol)

Snippet

Sponsor: Michael Iv | Conditions: Brain Injury, Central Nervous System Degenerative Disorder | EARLY_Phase 1 | Status: COMPLETED